Fig. 5
The relationships between the sIRGs and clinical features and the analysis of immune status of the high-risk group and low-risk group by PCA. Relationships between sIRGs and clinical characteristics. The expression levels of INHBA were increased in more advanced T-stages. A The expression levels of INHBA and JAG2 were increased in advanced N-stages. B The expression levels of JAG2 were decreased in early M-stages. C (*P < 0.05; **P < 0.01; ***P < 0.001) The ROC curves of various clinical features and IRRSM. D Nomogram was used for predicting 1, 3, and 5-year survival probability of CCa patients. E The high‐risk group and the low‐risk group were analyzed by the whole gene sets (F). The high‐risk group and the low‐risk group were analyzed based on the immune risk gene sets (G)